Abstract
Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 415-417 |
| Number of pages | 3 |
| Journal | Journal of Invasive Cardiology |
| Volume | 21 |
| Issue number | 8 |
| State | Published - Aug 2009 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine